This is a proof-of-concept randomized clinical trial of psilocybin-enhanced psychotherapy versus treatment-as-usual among individuals being treated for methamphetamine use disorder.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Acceptability
Timeframe: End of 6-week intervention; approximately 42 days
Proportion of patients who complete the intervention and follow-up
Timeframe: End of 6-week intervention to 180 days post-discharge follow-up; approximately 180 days